234 related articles for article (PubMed ID: 32914146)
1. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin.
Stack A; Ali N; Khan N
J Cell Immunol; 2020 May; 2(3):80-89. PubMed ID: 32914146
[TBL] [Abstract][Full Text] [Related]
2. Brentuximab vedotin as monotherapy for unresectable breast implant-associated anaplastic large cell lymphoma.
Stack A; Levy I
Clin Case Rep; 2019 May; 7(5):1003-1006. PubMed ID: 31110735
[TBL] [Abstract][Full Text] [Related]
3. Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature.
Richardson K; Alrifai T; Grant-Szymanski K; Kouris GJ; Venugopal P; Mahon B; Karmali R
Mol Clin Oncol; 2017 Apr; 6(4):539-542. PubMed ID: 28413663
[TBL] [Abstract][Full Text] [Related]
4. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
5. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management.
St Cyr TL; Pockaj BA; Northfelt DW; Craig FE; Clemens MW; Mahabir RC
Plast Surg (Oakv); 2020 May; 28(2):117-126. PubMed ID: 32596187
[TBL] [Abstract][Full Text] [Related]
6. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
7. Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease.
Evans MG; Medeiros LJ; Marques-Piubelli ML; Wang HY; Ortiz-Hidalgo C; Pina-Oviedo S; Morine A; Clemens MW; Hunt KK; Iyer S; Hu Q; Recavarren C; Demichelis R; Romero M; Sohani AR; Misialek M; Amin MB; Bueso-Ramos CE; Carballo-Zarate AA; Lee HJ; Ok CY; Xu J; Miranda RN
Mod Pathol; 2021 Dec; 34(12):2148-2153. PubMed ID: 34155351
[TBL] [Abstract][Full Text] [Related]
8. Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
Agrusa JE; Egress ER; Lowe EJ
Front Immunol; 2023; 14():1203471. PubMed ID: 37275877
[TBL] [Abstract][Full Text] [Related]
9. An Unusual Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Premji S; Barbieri A; Roth C; Rohren EM; Rivero G; Teegavarapu SP
Case Rep Hematol; 2022; 2022():4700787. PubMed ID: 35721802
[TBL] [Abstract][Full Text] [Related]
10. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
11. Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma.
Alderuccio JP; Desai A; Yepes MM; Chapman JR; Vega F; Lossos IS
Clin Case Rep; 2018 Apr; 6(4):634-637. PubMed ID: 29636930
[TBL] [Abstract][Full Text] [Related]
12. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
13. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
Fitzal F; Turner SD; Kenner L
Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
[TBL] [Abstract][Full Text] [Related]
14. Stage IV Breast Implant-associated Anaplastic Large-cell Lymphoma with Complete Pathologic Response to Neoadjuvant Chemotherapy.
Thibodeau R; Fan KL; Wehner PB
Plast Reconstr Surg Glob Open; 2019 Sep; 7(9):e2446. PubMed ID: 31942403
[TBL] [Abstract][Full Text] [Related]
15. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
16. Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
Lillemoe HA; Miranda RN; Nastoupil LJ; Clemens MW; Hunt KK
Ann Surg Oncol; 2022 Sep; 29(9):5722-5729. PubMed ID: 35597841
[TBL] [Abstract][Full Text] [Related]
17. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
Gravanis I; Tzogani K; van Hennik P; de Graeff P; Schmitt P; Mueller-Berghaus J; Salmonson T; Gisselbrecht C; Laane E; Bergmann L; Pignatti F
Oncologist; 2016 Jan; 21(1):102-9. PubMed ID: 26621039
[TBL] [Abstract][Full Text] [Related]
18. Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Clemens MW; DeCoster RC; Fairchild B; Bessonov AA; Santanelli di Pompeo F
Semin Plast Surg; 2019 Nov; 33(4):270-278. PubMed ID: 31632211
[TBL] [Abstract][Full Text] [Related]
19. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
20. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).
Lee JH
Yeungnam Univ J Med; 2021 Jul; 38(3):175-182. PubMed ID: 33461261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
